Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy
Purpose To investigate long-term treatment response after intravitreal bevacizumab injections (IVBIs) for central serous chorioretinopathy (CSC). Methods This retrospective, interventional study investigated the medical records of 45 eyes of 44 patients with CSC who underwent IBVIs and completed at...
Main Authors: | Hae Min Kang, Jeong Hoon Choi, Hyoung Jun Koh, Sung Chul Lee, Demetrios G. Vavvas |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478837/?tool=EBI |
Similar Items
-
Long-term treatment response after intravitreal bevacizumab injections for patients with central serous chorioretinopathy.
by: Hae Min Kang, et al.
Published: (2020-01-01) -
Intravitreal bevacizumab for treatment of central serous chorioretinopathy
by: Cihan Ünlü, et al.
Published: (2016-01-01) -
Intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
by: Amr Abdel-Fattah Ali Gab-Alla
Published: (2015-01-01) -
Intravitreal bevacizumab for subfoveal choroidal neovascularization complicating active central serous chorioretinopathy
by: Subrata Mandal, et al.
Published: (2011-01-01) -
Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy
by: Aditya Kelkar, et al.
Published: (2014-07-01)